ArticleCancer genomics & proteomics

GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer.

Tomoyuki Tatenuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.